IE
GMAB icon

Israel Englander’s Genmab GMAB Stock Holding History

Israel Englander’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-128,100
Closed -$2.67M – 6053
2024
Q4 		$2.67M Buy
+128,100
New +$2.81M ﹤0.01% 3394
2021
Q4 		– Sell
-50,000
Closed -$2.19M – 7011
2021
Q3 		$2.19M Buy
+50,000
New +$2.24M ﹤0.01% 3804

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Israel Englander's GMAB Position: Q2 2026 in Review

Israel Englander increased its Genmab (GMAB) stake by 15% in Q2 2026, buying an estimated $3.14M and bringing the position to 910,604 shares worth $25M. The position accounts for 0.01% of the portfolio, ranked #1428.

Israel Englander first reported a position in GMAB in Q3 2019 and has held it in 25 quarters since. The position peaked at $39M in Q4 2022. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Israel Englander held 910,604 shares of Genmab worth $25M as of Q2 2026.
  • Israel Englander bought 118,311 Genmab shares in Q2 2026, an estimated $3.14M.
  • Genmab made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1428 holding.
  • Israel Englander first reported a position in Genmab in Q3 2019 and has held it in 25 quarters since.
  • Israel Englander's Genmab position peaked at $39M in Q4 2022.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.